Citadel Advisors’s Carlsmed CARL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$953K Sell
67,706
-34,020
-33% -$473K ﹤0.01% 8593
2026
Q2
$1.06M Buy
101,726
+57,131
+128% +$601K ﹤0.01% 8066
2026
Q1
$404K Buy
+44,595
New +$539K ﹤0.01% 9799
2025
Q4
– Sell
-110,000
Closed -$1.47M – 14663
2025
Q3
$1.47M Buy
+110,000
New +$1.5M ﹤0.01% 6712

Other funds holding CARL

Citadel Advisors's CARL Position: Q3 2026 in Review

Citadel Advisors reduced its Carlsmed (CARL) stake by 33% in Q3 2026, selling an estimated $473K and leaving 67,706 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #8593.

Citadel Advisors first reported a position in CARL in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.47M in Q3 2025. 87 funds tracked by Wall St. Rank hold CARL as of Q3 2026.

  • Citadel Advisors held 67,706 shares of Carlsmed worth $953K as of Q3 2026.
  • Citadel Advisors sold 34,020 Carlsmed shares in Q3 2026, an estimated $473K.
  • Carlsmed made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #8593 holding.
  • Citadel Advisors first reported a position in Carlsmed in Q3 2025 and has held it in 4 quarters since.
  • Citadel Advisors's Carlsmed position peaked at $1.47M in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Carlsmed as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.